Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal Trial Enrollment

Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March 10, 2026 ...

Femasys Inc.: Femasys Advances FemBloc Toward U.S. Approval with Initiation of Pivotal ...

Enrollment begins in the FDA-authorized FINALE pivotal trial evaluating FemBloc, a first-of-its-kind non-surgical permanent birth control, following positive clinical data -- ATLANTA, March 10, 2026 ...